192 related articles for article (PubMed ID: 32936291)
21. Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study.
Terui T; Okubo Y; Kobayashi S; Sano S; Morita A; Imafuku S; Tada Y; Abe M; Yaguchi M; Uehara N; Handa T; Tanaka M; Zhang W; Paris M; Murakami M
Am J Clin Dermatol; 2023 Sep; 24(5):837-847. PubMed ID: 37233897
[TBL] [Abstract][Full Text] [Related]
22. Inclusion of Smoking Data in Cardiovascular Disease Risk Estimation.
Duncan MS; Greevy RA; Tindle HA; Vasan RS; Lipworth L; Aldrich MC; Lloyd-Jones DM; Freiberg MS
JAMA Cardiol; 2022 Feb; 7(2):195-203. PubMed ID: 34878493
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics and associations of palmoplantar pustulosis: an observational study.
Oktem A; Uysal PI; Akdoğan N; Tokmak A; Yalcin B
An Bras Dermatol; 2020; 95(1):15-19. PubMed ID: 31899067
[TBL] [Abstract][Full Text] [Related]
24. Refractory Palmoplantar Pustulosis Successfully Treated with JAK Inhibitor Tofacitinib: A Case Series.
Xu Q; Wang X; Yang A; Wei G
Infect Drug Resist; 2023; 16():5165-5172. PubMed ID: 37581169
[TBL] [Abstract][Full Text] [Related]
25. Effect of monochromatic excimer light on palmoplantar pustulosis: a clinical study performed in a private clinic by a dermatological specialist.
Fumimori T; Tsuruta D; Kawakami T; Ohata C; Furumura M; Hashimoto T
J Dermatol; 2013 Dec; 40(12):1004-7. PubMed ID: 24303875
[TBL] [Abstract][Full Text] [Related]
26. Treatment of Severe Palmoplantar Pustular Psoriasis With Bimekizumab.
Passeron T; Perrot JL; Jullien D; Goujon C; Ruer M; Boyé T; Villani AP; Quiles Tsimaratos N
JAMA Dermatol; 2024 Feb; 160(2):199-203. PubMed ID: 38054800
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database.
Kubota K; Kamijima Y; Sato T; Ooba N; Koide D; Iizuka H; Nakagawa H
BMJ Open; 2015 Jan; 5(1):e006450. PubMed ID: 25588781
[TBL] [Abstract][Full Text] [Related]
28. Sustained efficacy and safety of guselkumab in patients with palmoplantar pustulosis through 1.5 years in a randomized phase 3 study.
Okubo Y; Morishima H; Zheng R; Terui T
J Dermatol; 2021 Dec; 48(12):1838-1853. PubMed ID: 34453358
[TBL] [Abstract][Full Text] [Related]
29. Clinical and genetic differences between pustular psoriasis subtypes.
Twelves S; Mostafa A; Dand N; Burri E; Farkas K; Wilson R; Cooper HL; Irvine AD; Oon HH; Kingo K; Köks S; Mrowietz U; Puig L; Reynolds N; Tan ES; Tanew A; Torz K; Trattner H; Valentine M; Wahie S; Warren RB; Wright A; Bata-Csörgő Z; Szell M; Griffiths CEM; Burden AD; Choon SE; Smith CH; Barker JN; Navarini AA; Capon F
J Allergy Clin Immunol; 2019 Mar; 143(3):1021-1026. PubMed ID: 30036598
[TBL] [Abstract][Full Text] [Related]
30. A randomised placebo controlled trial of anakinra for treating pustular psoriasis: statistical analysis plan for stage two of the APRICOT trial.
Cro S; Patel P; Barker J; Burden DA; Griffiths CEM; Lachmann HJ; Reynolds NJ; Warren RB; Capon F; Smith C; Cornelius V
Trials; 2020 Feb; 21(1):158. PubMed ID: 32041649
[TBL] [Abstract][Full Text] [Related]
31. Apremilast in Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Meta-analysis.
Spencer RK; Elhage KG; Jin JQ; Davis MS; Hakimi M; Bhutani T; Liao W
Dermatol Ther (Heidelb); 2023 Feb; 13(2):437-451. PubMed ID: 36609960
[TBL] [Abstract][Full Text] [Related]
32. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
33. Interventions for chronic palmoplantar pustulosis.
Obeid G; Do G; Kirby L; Hughes C; Sbidian E; Le Cleach L
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011628. PubMed ID: 31958161
[TBL] [Abstract][Full Text] [Related]
34. Local injection of micro-dose anti-interleukin-17A antibody for palmoplantar pustulosis: A real-world study.
Xia R; Liu J; Gao Y; Diao Z; Chen D; Zhou C; Zhang Z; Yin Z
Clin Immunol; 2023 Aug; 253():109694. PubMed ID: 37433424
[TBL] [Abstract][Full Text] [Related]
35. Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT).
Cro S; Cornelius VR; Pink AE; Wilson R; Pushpa-Rajah A; Patel P; Abdul-Wahab A; August S; Azad J; Becher G; Chapman A; Dunnil G; Ferguson AD; Fogo A; Ghaffar SA; Ingram JR; Kavakleiva S; Ladoyanni E; Leman JA; Macbeth AE; Makrygeoegou A; Parslew R; Ryan AJ; Sharma A; Shipman AR; Sinclair C; Wachsmuth R; Woolf RT; Wright A; McAteer H; Barker JNWN; Burden AD; Griffiths CEM; Reynolds NJ; Warren RB; Lachmann HJ; Capon F; Smith CH;
Br J Dermatol; 2021 Aug; 186(2):245-56. PubMed ID: 34411292
[TBL] [Abstract][Full Text] [Related]
36. Clinical characteristics, genetics, comorbidities and treatment of palmoplantar pustulosis: A retrospective analysis of 66 cases in a single center in Taiwan.
Huang CM; Tsai TF
J Dermatol; 2020 Sep; 47(9):1046-1049. PubMed ID: 32613680
[TBL] [Abstract][Full Text] [Related]
37. Lung function decline in former smokers and low-intensity current smokers: a secondary data analysis of the NHLBI Pooled Cohorts Study.
Oelsner EC; Balte PP; Bhatt SP; Cassano PA; Couper D; Folsom AR; Freedman ND; Jacobs DR; Kalhan R; Mathew AR; Kronmal RA; Loehr LR; London SJ; Newman AB; O'Connor GT; Schwartz JE; Smith LJ; White WB; Yende S
Lancet Respir Med; 2020 Jan; 8(1):34-44. PubMed ID: 31606435
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a Case Series of Patients With Palmoplantar Pustulosis in the United States.
Noe MH; Wan MT; Mostaghimi A; Gelfand JM; ; Agnihothri R; Armstrong AW; Bhutani T; Bridges A; Brownstone N; Butt M; Duffin KPC; Carr C; Creadore A; DeNiro KL; Desai S; Dominguez AR; Duffy EK; Fairley JA; Femia A; Gudjonsson JE; Kaffenberger JA; Katz KL; Kirby JS; Le ST; Martinez E; Maverakis E; Myers B; Naik HB; Nelson CA; Ortega-Loayza AG; Plovanich ME; Rangel LK; Ravi V; Reddy VD; Saleh JZ; Sandhu JK; Shakshouk H; Shields BE; Sharif-Sidi Z; Smith J; Steahr A; Toussi A; Wanat KA; Wang B; Wei BM; Weinhammer A; Worswick SD; Yang A
JAMA Dermatol; 2022 Jan; 158(1):68-72. PubMed ID: 34878495
[TBL] [Abstract][Full Text] [Related]
39. Economic burden of generalized pustular psoriasis and palmoplantar pustulosis in the United States.
Hanna ML; Singer D; Valdecantos WC
Curr Med Res Opin; 2021 May; 37(5):735-742. PubMed ID: 33622113
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the area subscore of the Palmoplantar Pustulosis Area and Severity Index using an attention U-net deep learning algorithm.
Paik K; Kim BR; Youn SW
J Dermatol; 2023 Jun; 50(6):787-792. PubMed ID: 36815336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
